Senior insider sale
Senior Vice President, CCO at Y-MABS THERAPEUTICS, INC. — senior position signals high conviction
$29.1K
5.53K shares
What this filing means
SMITH SUSAN LAURA plans to sell 5.53K shares of Y-MABS THERAPEUTICS, INC. valued at approximately $29.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/7/2025ACC: 0001964306-25-000143
Officer· Senior Vice President, CCO
Since Dec 2021
5.53K
Shares to sell
$29.1K
Approx. market value
5.53K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
1/18/2025
2.76KVesting of restricted stock unit award
Granted as part of issuer equity compensation plan
1/17/2025
2.76KTotal acquired5.53K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/18/2025 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 2.76K | — |
1/17/2025 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 2.76K | — |
| Total | 5.53K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
5.53K
Market value
$29.1K
3/7/2025
Total
Units
5.53K
Value
$29.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/7/2025 | 5.53K | $29.1K | NASDAQ | Planned |
| Total | 5.53K | $29.1K | ||